Skip to search formSkip to main contentSkip to account menu

OPC 14117

Known as: 1-Piperazineacetamide, N-(2,3-dihydro-7-hydroxy-2,2,4,6-tetramethyl-1H-inden-1-yl)-4-(3-methoxyphenyl)-, OPC-14117 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
The excitotoxic response of striatal neurons to NMDA and non-NMDA receptor agonists involves the nuclear translocation of… 
1998
1998
Oxygen free radicals contribute to various kinds of tissue injury processes within the central nervous system. It has been… 
1998
1998
Oxidative damage due to free-radical generation in the setting of underlying defects of neuronal energy metabolism has been… 
1998
1998
The development of a validated primate model of progressive parkinsonism is a critical step in the evaluation of drugs that might… 
1997
1997
A possible protective effect of a novel free radical scavenger, OPC‐14117, on the progressive motor neuron death in wobbler mice… 
1997
1997
Oxygen free radicals may contribute to tissue injury processes in the central nervous system following ischemia or trauma. Recent… 
1997
1997
Cognitive impairment is a common and disabling complication of advanced HIV infection. Antiretroviral agents are the only proven… 
1991
1991
OPC-14117 is a potent drug which has both brain function activating effect and protective effect against cerebral ischemia… 
1991
1991
In a continuous search for a novel cerebroprotective drug with a central nervous system (CNS) stimulating activity, a series of 1…